Andere Sprachen SOPHiA GENETICS SA

Aktien

A3CVT8

CH1125843347

SOPH

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 21.06.2024			% 5 Tage	% 1. Jan.
4,72 ^USD	+0,43 %		-2,28 %	+0,21 %

29.05.	Sektor-Update: Aktien des Gesundheitswesens fallen am spaten Nachmittag	MT
29.05.	Sophia Genetics erholt sich am Mittwoch nach einer Partnerschaft mit Microsoft und Nvidia fur eine Whole Genome Analytics Plattform	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

SOPHiA GENETICS : IUCT Oncopole Becomes First French Hospital to Adopt MSK ACCESS® powered with SOPHiA DDM™	20.06.
SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM Platform	14.06.
SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform	13.06.
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care	30.05.
Sector Update: Health Care Stocks Fall Late Afternoon	29.05.
Sophia Genetics Rallies Wednesday after Partnering with Microsoft, Nvidia on Whole Genome Analytics Platform	29.05.
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities	29.05.
SOPHiA GENETICS SA to Launch New Whole Genome Sequencing Capabilities	29.05.
SOPHiA GENETICS Announces Instituto Mario Penna as New Customer	21.05.
SOPHiA GENETICS Announces Instituto Mário Penna as New Customer	20.05.
SOPHiA GENETICS Announces Instituto Mário Penna as New Customer	20.05.
Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS	16.05.
SOPHiA GENETICS SA Reports Earnings Results for the First Quarter Ended March 31, 2024	07.05.
SOPHiA GENETICS Reports First Quarter 2024 Results	07.05.
SOPHiA GENETICS Reiterates Earnings Guidance for the Full Year 2024	07.05.
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference	30.04.
SOPHiA GENETICS : to Present at the 2024 RBCCM Global Healthcare Conference	30.04.
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024	23.04.
Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering	23.04.
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa	23.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen SOPHiA GENETICS SA

Aktien

A3CVT8

CH1125843347

SOPH

Andere Sprachen

Filter